LivaNova (NASDAQ:LIVN) Trading Up 6.2% – Should You Buy?

LivaNova PLC (NASDAQ:LIVNGet Free Report)’s stock price traded up 6.2% during mid-day trading on Tuesday . The company traded as high as $55.32 and last traded at $55.01. 69,295 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 618,200 shares. The stock had previously closed at $51.81.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. The Goldman Sachs Group initiated coverage on LivaNova in a research note on Friday, October 4th. They set a “buy” rating and a $65.00 target price for the company. Robert W. Baird lifted their price target on shares of LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a report on Thursday, October 31st. Baird R W upgraded LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 17th. Needham & Company LLC restated a “buy” rating and set a $75.00 price target on shares of LivaNova in a report on Tuesday. Finally, Stifel Nicolaus boosted their target price on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a report on Thursday, July 25th. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $69.17.

Check Out Our Latest Research Report on LivaNova

LivaNova Trading Up 1.1 %

The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The firm’s fifty day moving average is $51.47 and its 200-day moving average is $52.98. The firm has a market cap of $2.91 billion, a price-to-earnings ratio of 127.57 and a beta of 1.01.

Institutional Investors Weigh In On LivaNova

A number of hedge funds have recently added to or reduced their stakes in the business. Arizona State Retirement System lifted its position in shares of LivaNova by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 15,104 shares of the company’s stock valued at $828,000 after acquiring an additional 299 shares during the period. Atria Investments Inc raised its holdings in shares of LivaNova by 6.2% during the third quarter. Atria Investments Inc now owns 5,653 shares of the company’s stock valued at $297,000 after purchasing an additional 331 shares during the period. Fifth Third Bancorp boosted its position in shares of LivaNova by 97.1% during the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after purchasing an additional 332 shares in the last quarter. Hexagon Capital Partners LLC grew its stake in shares of LivaNova by 117.8% in the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock valued at $37,000 after buying an additional 370 shares during the period. Finally, State of Alaska Department of Revenue increased its position in LivaNova by 7.3% in the 3rd quarter. State of Alaska Department of Revenue now owns 6,246 shares of the company’s stock valued at $328,000 after buying an additional 425 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

(Get Free Report)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Read More

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.